Survivin and escaping in therapy‐induced cellular senescence
Open Access
- 28 January 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 128 (7), 1546-1558
- https://doi.org/10.1002/ijc.25482
Abstract
Therapy‐induced accelerated cellular senescence (ACS) is a reversible tumor response to chemotherapy that is likely detrimental to the overall therapeutic efficacy of cancer treatment. To further understand the mechanism by which cancer cells can escape the sustained cell cycle arrest in ACS, we established a tissue culture model, in which the p53‐null NCI‐H1299 cells can be induced into senescence by an abbreviated exposure to a chemotherapeutic agent. Previously, we have reported that senescent cells overexpress Cdc2/Cdk1 when they bypassed the prolonged arrest and their viability is dependent on Cdc2/Cdk1 kinase activity. In our study, we show that human survivin is the immediate downstream effector of the Cdc2/Cdk1 mediated survival signal. Survivin cooperates with Cdc2/Cdk1 to inhibit apoptosis following chemotherapy and promote senescence escape. Using HIV‐1 TAT peptides to disrupt survivin phosphorylation by Cdc2/Cdk1, we also found that phosphorylated survivin is necessary both for the escape of senescent cells and for maintenance of subsequent viability after bypassing senescence. These results further propose survivin as an important determinant of senescence reversibility and as a putative molecular target to enforce cell death in ACS.Keywords
This publication has 41 references indexed in Scilit:
- Oncogene-Induced Cell Senescence — Halting on the Road to CancerNew England Journal of Medicine, 2006
- Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonistOncogene, 2006
- Survivin and p53 Modulate Quercetin-induced Cell Growth Inhibition and Apoptosis in Human Lung Carcinoma CellsJournal of Biological Chemistry, 2004
- Effects of statins and farnesyltransferase inhibitors on the development and progression of cancerCancer Treatment Reviews, 2004
- Phosphatidylinositol 3-Kinase/Akt Regulates Angiotensin II–Induced Inhibition of Apoptosis in Microvascular Endothelial Cells by Governing Survivin Expression and Suppression of Caspase-3 ActivityCirculation Research, 2004
- Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosisOncogene, 2004
- Survivin study: What is the next wave?Journal of Cellular Physiology, 2003
- Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastropheCell Death & Differentiation, 2002
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999